Source:http://linkedlifedata.com/resource/pubmed/id/21173117
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2011-4-1
|
pubmed:abstractText |
Because lymphoid progenitors can give rise to natural killer (NK) cells, NK ontogeny has been considered to be exclusively lymphoid. Here, we show that rare human CD34(+) hematopoietic progenitors develop into NK cells in vitro in the presence of cytokines (interleukin-7, interleukin-15, stem cell factor, and fms-like tyrosine kinase-3 ligand). Adding hydrocortisone and stromal cells greatly increases the frequency of progenitor cells that give rise to NK cells through the recruitment of myeloid precursors, including common myeloid progenitors and granulocytic-monocytic precursors to the NK-cell lineage. WNT signaling was involved in this effect. Cells at more advanced stages of myeloid differentiation (with increasing expression of CD13 and macrophage colony-stimulating factor receptor [M-CSFR]) could also differentiate into NK cells in the presence of cytokines, stroma, and hydrocortisone. NK cells derived from myeloid precursors (CD56(-)CD117(+)M-CSFR(+)) showed more expression of killer immunoglobulin-like receptors, a fraction of killer immunoglobulin-like receptor-positive-expressing cells that lacked NKG2A, a higher cytotoxicity compared with CD56(-)CD117(+)M-CSFR(-) precursor-derived NK cells and thus resemble the CD56(dim) subset of NK cells. Collectively, these studies show that NK cells can be derived from the myeloid lineage.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/P01 111412,
http://linkedlifedata.com/resource/pubmed/grant/P01 CA65493,
http://linkedlifedata.com/resource/pubmed/grant/P01067493,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA72669,
http://linkedlifedata.com/resource/pubmed/grant/R01 HL55417
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1528-0020
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
31
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3548-58
|
pubmed:meshHeading |
pubmed-meshheading:21173117-Antigens, CD34,
pubmed-meshheading:21173117-Antigens, CD56,
pubmed-meshheading:21173117-Cell Count,
pubmed-meshheading:21173117-Cell Differentiation,
pubmed-meshheading:21173117-Cells, Cultured,
pubmed-meshheading:21173117-Colony-Forming Units Assay,
pubmed-meshheading:21173117-Humans,
pubmed-meshheading:21173117-Hydrocortisone,
pubmed-meshheading:21173117-K562 Cells,
pubmed-meshheading:21173117-Killer Cells, Natural,
pubmed-meshheading:21173117-Myeloid Progenitor Cells,
pubmed-meshheading:21173117-Stromal Cells,
pubmed-meshheading:21173117-Up-Regulation
|
pubmed:year |
2011
|
pubmed:articleTitle |
Natural killer-cell differentiation by myeloid progenitors.
|
pubmed:affiliation |
Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, 425 E. River Road, Minneapolis, MN 55455, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|